Correction to: Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease

James Lomas (), Miqdad Asaria, Laura Bojke, Chris P. Gale, Gerry Richardson and Simon Walker
Additional contact information
James Lomas: University of York
Laura Bojke: University of York
Chris P. Gale: University of Leeds
Gerry Richardson: University of York

PharmacoEconomics - Open, 2019, vol. 3, issue 2, No 18, 277-277

Abstract: The original article can be found online.

Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s41669-019-0129-0 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharmo:v:3:y:2019:i:2:d:10.1007_s41669-019-0129-0

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/41669

DOI: 10.1007/s41669-019-0129-0

Access Statistics for this article

PharmacoEconomics - Open is currently edited by Timothy Wrightson and Christopher Carswell

More articles in PharmacoEconomics - Open from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().